In February, the Federal Trade Commission (FTC) published a notice on health-care competition. APMA submitted a comment letter in response to this FTC notice last week. It addressed the education, training, and experience of podiatrists, as well as scope of practice laws and other legislative and regulatory restrictions that do not reflect the advancement of podiatric medicine and the value of care by podiatrists.
This content is available to APMA members only. If you are a member, please log in to see the full content.